MedPath

ECG AI-Guided Screening for Low Ejection Fraction

Not Applicable
Completed
Conditions
Asymptomatic Left Ventricular Systolic Dysfunction (Disorder)
Heart Failure
Registration Number
NCT04000087
Lead Sponsor
Mayo Clinic
Brief Summary

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of left ventricular systolic dysfunction.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
358
Inclusion Criteria
  • Primary care clinicians who are part of a participating care team that care for adult patients and have the ability to order ECG and TTE (this includes physicians, nurse practitioners, and physician assistants).
Exclusion Criteria
  • Primary care clinicians working in pediatrics, acute care, nursing homes, and resident care teams.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
New Diagnosis of Low Ejection Fraction (defined as ejection fraction ≤50%)Within 90 days

Ejection fraction obtained by echocardiography.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

Mayo Clinic in Rochester
🇺🇸Rochester, Minnesota, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.